A Novel Class of Phosphonate Nucleosides. 9-[(1-Phosphonomethoxycyclopropyl)methyl]guanine as a Potent and Selective Anti-HBV Agent
Authors:
- 16 April 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (11) , 2864-2869
Abstract
9-[1-(Phosphonomethoxycyclopropyl)methyl]guanine (PMCG, 1), representative of a novel class of phosphonate nucleosides, blocks HBV replication with excellent potency (EC50 = 0.5 μM) in a primary culture of HepG2 2.2.15 cells. It exhibits no significant cytotoxicity in several human cell lines up to 1.0 mM. It does not inhibit replication of human immunodeficiency virus (HIV-1) or herpes simplex virus (HSV-1) at 30 μM. Many purine base analogues of 1 also exhibit inhibitory activity against HBV, but at 30 μM, pyrimidine analogues do not. 1 is 4 times more potent than 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA), which was used as a positive control (EC50 = 2.0 μM). The characteristic cyclopropyl moiety at the 2‘-position of 1 was prepared by titanium-mediated Kulinkovich cyclopropanation. 1 was modified to give the orally available drug candidate, PMCDG Dipivoxil (2). Compound 2 exhibited excellent efficacy when administered at 5 mg per kg per day in a study with woodchucks infected with woodchuck hepatitis B virus (WHBV). Drug candidate 2 has successfully completed phase I clinical trials and is currently undergoing phase II clinical studies for evaluation of efficacy.Keywords
This publication has 11 references indexed in Scilit:
- Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis BNew England Journal of Medicine, 2003
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- Perspectives for the treatment of hepatitis B virus infectionsInternational Journal of Antimicrobial Agents, 1999
- Adefovir DipivoxilDrugs, 1999
- Advances in the treatment of chronic hepatitis B virus infectionReviews in Medical Virology, 1998
- Synthesis, Oral Bioavailability Determination, and in vitro Evaluation of Prodrugs of the Antiviral Agent 9-[2-(Phosphonomethoxy)ethyl]adenine (PMEA)Journal of Medicinal Chemistry, 1994
- Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent.Proceedings of the National Academy of Sciences, 1989
- Long-term follow-up of anti-HBe-positive chronic active hepatitis BHepatology, 1988
- Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.Proceedings of the National Academy of Sciences, 1987
- Cyclopropylcarbinyl pentamethylbenzenesulfonate solvolysis. A study of response to solvent ionizing strengthThe Journal of Organic Chemistry, 1979